Lactisole interacts with the transmembrane domains of human T1R3 to inhibit sweet taste
Peihua Jiang, Meng Cui, Baohua Zhao, Zhan Liu, Lenore A Snyder, Lumie M J Benard, Roman Osman, Robert F Margolskee, Marianna Max, Peihua Jiang, Meng Cui, Baohua Zhao, Zhan Liu, Lenore A Snyder, Lumie M J Benard, Roman Osman, Robert F Margolskee, Marianna Max
Abstract
The detection of sweet-tasting compounds is mediated in large part by a heterodimeric receptor comprised of T1R2+T1R3. Lactisole, a broad-acting sweet antagonist, suppresses the sweet taste of sugars, protein sweeteners, and artificial sweeteners. Lactisole's inhibitory effect is specific to humans and other primates; lactisole does not affect responses to sweet compounds in rodents. By heterologously expressing interspecies combinations of T1R2+T1R3, we have determined that the target for lactisole's action is human T1R3. From studies with mouse/human chimeras of T1R3, we determined that the molecular basis for sensitivity to lactisole depends on only a few residues within the transmembrane region of human T1R3. Alanine substitution of residues in the transmembrane region of human T1R3 revealed 4 key residues required for sensitivity to lactisole. In our model of T1R3's seven transmembrane helices, lactisole is predicted to dock to a binding pocket within the transmembrane region that includes these 4 key residues.
Source: PubMed